Vikas Saini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vikas Saini has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Lakshmi Narayana Yaddanapudi
Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India
3 shared publications - Neeru Sahni
Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh, India
3 shared publications - Sameer Sethi
Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India
3 shared publications - Anjishnujit Bandyopadhyay
Department of Anaesthesiology, Pain Medicine and Critical Care, Jai Prakash Narayan Apex Trauma Center, All India Institute of Medical Sciences, New Delhi, India
2 shared publications - Sandeep Grover
Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 shared publications - Sunaakshi Puri
Nehru Hospital, India
2 shared publications
Latest Publications
- Open Access
- 11 July 2026
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 22 (3) , 1-4
Cochlear Implantation in Arnold–Chiari Malformation Type 1: Expanding the Boundaries of Pediatric Neuro-Otology
Arnold–Chiari malformation (ACM) is a rare congenital hindbrain anomaly, with types 1-4 depending of degree of herniation of posterior fossa contents. The incidence of type 1 ACM is highest, with most cases being asymptomatic. Cases are incidentally picked up; however, some may present with headache, cough, paresthesia, and very rarely, symptoms of compression of lower cranial nerves such as sensorineural hearing loss. Surgical challenges are anticipated due to associated skeletal malformations and raised intracranial pressure. The youngest reported case—a 3-year-old girl with delayed speech and language milestones—is presented, in whom ACM type 1 was incidentally diagnosed. Audiological workup revealed profound sensorineural hearing loss in both ears. After multidisciplinary clearance, she underwent right-sided cochlear implantation. Intraoperative challenges faced were dilated emissary veins, an anteriorly placed sigmoid sinus, and a low-lying dura. However, a full electrode insertion was achieved and confirmed on neural response telemetry. The postoperative course was uneventful. Literature review suggests this to be the youngest reported case of cochlear implantation in ACM type 1. While hearing loss in this case may have been unrelated to ACM, nonetheless, successful cochlear implantation is feasible with meticulous preoperative planning and intraoperative vigilance. After a thorough anatomical assessment, multidisciplinary preoperative workup, intraoperative vigilance, and neuro-anesthetist backup, cochlear implantation can be safely performed in children with ACM type 1.
- 11 July 2026
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 22 (3) , 1-4
Open AccessCochlear Implantation in Arnold–Chiari Malformation Type 1: Expanding the Boundaries of Pediatric Neuro-Otology
Arnold–Chiari malformation (ACM) is a rare congenital hindbrain anomaly, with types 1-4 depending of degree of herniation of posterior fossa contents. The incidence of type 1 ACM is highest, with most cases being asymptomatic. Cases are incidentally picked up; however, some may present with headache, cough, paresthesia, and very rarely, symptoms of compression of lower cranial nerves such as sensorineural hearing loss. Surgical challenges are anticipated due to associated skeletal malformations and raised intracranial pressure. The youngest reported case—a 3-year-old girl with delayed speech and language milestones—is presented, in whom ACM type 1 was incidentally diagnosed. Audiological workup revealed profound sensorineural hearing loss in both ears. After multidisciplinary clearance, she underwent right-sided cochlear implantation. Intraoperative challenges faced were dilated emissary veins, an anteriorly placed sigmoid sinus, and a low-lying dura. However, a full electrode insertion was achieved and confirmed on neural response telemetry. The postoperative course was uneventful. Literature review suggests this to be the youngest reported case of cochlear implantation in ACM type 1. While hearing loss in this case may have been unrelated to ACM, nonetheless, successful cochlear implantation is feasible with meticulous preoperative planning and intraoperative vigilance. After a thorough anatomical assessment, multidisciplinary preoperative workup, intraoperative vigilance, and neuro-anesthetist backup, cochlear implantation can be safely performed in children with ACM type 1.
- Open Access
- 20 May 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (5) , 653-661
Effect of sugammadex versus neostigmine/glycopyrrolate combination on peak expiratory flow rates in adult patients undergoing laparoscopic surgery
Background and Aims: Residual neuromuscular blockade impacts peak expiratory flow rate (PEFR). The primary aim of this study was to compare post-extubation PEFR in adults undergoing laparoscopic cholecystectomy when neuromuscular blockade was reversed by either neostigmine or sugammadex. Methods: Patients aged 18–60 years were randomised into two equal groups of 43 each based on the reversal agent used – sugammadex versus neostigmine. Pre- and post-operative PEFRs were recorded using a handheld flow-type spirometer. Percentage reduction in forced expiratory volume in first second (FEV1), forced vital capacity (FVC), and FEV1/FVC were calculated. Adverse events and recovery scores were compared between the two groups. Results: The post-operative PEFR with sugammadex was 336.88 ± 65.94 L/min, compared to 293.93 ± 43.76 L/min with neostigmine. The mean difference was statistically significant {42.95 L/min [95% confidence interval (CI): 18.95–66.95 L/min], P = 0.001}. The mean percentage reduction in PEFR from baseline was significantly lower with sugammadex (9.66 ± 6.11%) compared to neostigmine (16.33 ± 10.9%). The median time to extubation with sugammadex was 3 min [interquartile range (IQR): 3–4)], and 7 min (IQR: 6–8) with neostigmine ( P = 0.001). The time to achieve modified Aldrete score >8 with sugammadex was shorter by an absolute difference of 8.814 (CI = 10.28–7.35) min. No incidence of post-operative pulmonary complication (PPC) was reported in either group. Conclusion: Reversal of neuromuscular blockade with sugammadex is associated with higher post-operative values of PEFR when compared with neostigmine. Higher values of PEFR and FEV1, FVC, and FEV 1 /FVC ratio after surgery shorten the time to extubation, minimise PPC, and facilitate early post-operative recovery.
- 20 May 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (5) , 653-661
Open AccessEffect of sugammadex versus neostigmine/glycopyrrolate combination on peak expiratory flow rates in adult patients undergoing laparoscopic surgery
Background and Aims: Residual neuromuscular blockade impacts peak expiratory flow rate (PEFR). The primary aim of this study was to compare post-extubation PEFR in adults undergoing laparoscopic cholecystectomy when neuromuscular blockade was reversed by either neostigmine or sugammadex. Methods: Patients aged 18–60 years were randomised into two equal groups of 43 each based on the reversal agent used – sugammadex versus neostigmine. Pre- and post-operative PEFRs were recorded using a handheld flow-type spirometer. Percentage reduction in forced expiratory volume in first second (FEV1), forced vital capacity (FVC), and FEV1/FVC were calculated. Adverse events and recovery scores were compared between the two groups. Results: The post-operative PEFR with sugammadex was 336.88 ± 65.94 L/min, compared to 293.93 ± 43.76 L/min with neostigmine. The mean difference was statistically significant {42.95 L/min [95% confidence interval (CI): 18.95–66.95 L/min], P = 0.001}. The mean percentage reduction in PEFR from baseline was significantly lower with sugammadex (9.66 ± 6.11%) compared to neostigmine (16.33 ± 10.9%). The median time to extubation with sugammadex was 3 min [interquartile range (IQR): 3–4)], and 7 min (IQR: 6–8) with neostigmine ( P = 0.001). The time to achieve modified Aldrete score >8 with sugammadex was shorter by an absolute difference of 8.814 (CI = 10.28–7.35) min. No incidence of post-operative pulmonary complication (PPC) was reported in either group. Conclusion: Reversal of neuromuscular blockade with sugammadex is associated with higher post-operative values of PEFR when compared with neostigmine. Higher values of PEFR and FEV1, FVC, and FEV 1 /FVC ratio after surgery shorten the time to extubation, minimise PPC, and facilitate early post-operative recovery.
- Open Access
- 30 April 2026
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 21 (2) , 203-211
Effect of milrinone-terlipressin infusion on blood loss and portal pressure during hepatic resection: a randomized controlled trial
Background: Low central venous pressure (CVP) and Pringle maneuver are commonly employed strategies to reduce bleeding during hepatic resection. Milrinone and terlipressin lower hepatic venous pressure and portal venous pressure (PVP), thereby reducing the risk of bleeding. This study compared the intraoperative blood loss between a combined infusion of milrinone and terlipressin, and terlipressin alone in patients undergoing elective hepatic resection.Methods: A total of 36 patients were randomized to the Milrinone and terlipressin or Terlipressin groups, who received infusions starting 30 min before the beginning of liver resection until the end of the surgery. The primary objective was to determine differences in blood loss between the two groups.Results: Thirty-four patients (17 in each group) were assessed by stratification into major and minor hepatic resections. The median (1Q, 3Q) intraoperative blood loss (in ml) was lower in Milrinone and terlipressin group than in Terlipressin group (570 [329, 880] vs. 824 [750, 1,146]; P = 0.046). In minor resections, milrinone and terlipressin had lower blood loss than terlipressin (373 [273, 556] vs. 798 [725, 1,230]; P = 0.015). There is no difference between the two groups in blood loss during major hepatic resection. The decreases in PVP and CVP at 30 min post-infusion were significant in the Milrinone and terlipressin group (P = 0.002 and P = 0.027, respectively).Conclusions: The combination of milrinone and terlipressin significantly reduces intraoperative blood loss, especially during minor hepatic resections.
- 30 April 2026
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 21 (2) , 203-211
Open AccessEffect of milrinone-terlipressin infusion on blood loss and portal pressure during hepatic resection: a randomized controlled trial
Background: Low central venous pressure (CVP) and Pringle maneuver are commonly employed strategies to reduce bleeding during hepatic resection. Milrinone and terlipressin lower hepatic venous pressure and portal venous pressure (PVP), thereby reducing the risk of bleeding. This study compared the intraoperative blood loss between a combined infusion of milrinone and terlipressin, and terlipressin alone in patients undergoing elective hepatic resection.Methods: A total of 36 patients were randomized to the Milrinone and terlipressin or Terlipressin groups, who received infusions starting 30 min before the beginning of liver resection until the end of the surgery. The primary objective was to determine differences in blood loss between the two groups.Results: Thirty-four patients (17 in each group) were assessed by stratification into major and minor hepatic resections. The median (1Q, 3Q) intraoperative blood loss (in ml) was lower in Milrinone and terlipressin group than in Terlipressin group (570 [329, 880] vs. 824 [750, 1,146]; P = 0.046). In minor resections, milrinone and terlipressin had lower blood loss than terlipressin (373 [273, 556] vs. 798 [725, 1,230]; P = 0.015). There is no difference between the two groups in blood loss during major hepatic resection. The decreases in PVP and CVP at 30 min post-infusion were significant in the Milrinone and terlipressin group (P = 0.002 and P = 0.027, respectively).Conclusions: The combination of milrinone and terlipressin significantly reduces intraoperative blood loss, especially during minor hepatic resections.
- Open Access
- 26 April 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-11
Prevalence of frailty and its effect on requirement of organ support and clinical outcomes in critically ill patients: a prospective observational single center study
Assessing pre-hospital frailty on ICU admission can help in risk stratification. We conducted this prospective, observational study to determine the prevalence of frailty in critically ill patients based on Clinical Frailty Scale (CFS) within 24 h of admission and to study effect of frailty on requirement of organ support and clinical outcome. The study was registered in Clinical Trials Registry-India (CTRI/2021/04/032782) on 13/04/2021. After approval from IEC and written informed consent, all adult patients admitted to our ICU from April 15th, 2021 to April 14th, 2022 were included. The patients were categorized as Frail & Non-Frail, defining frailty as CFS ≥ 5, two weeks before index admission. The groups were compared for requirement of organ support (vasoactive support, mechanical ventilation, renal replacement therapy) and clinical outcomes (hospital acquired infections (HAI), hospital and ICU length of stay (LOS) and hospital, ICU and 30-day mortality). Out of 358 admissions, 317 were enrolled. The demographic data were comparable except for higher family income amongst frail patients, p < 0.001. The prevalence of frailty was 24.6%. A significantly higher number of frail patients required vasoactive support (p = 0.006). Incidence of HAI in frail group was significantly higher (48.7%) as compared to non-frail group (20.9%) (p < 0.001). The median ICU LOS was 7 days [IQR, 3–7] in frail compared to 6 days [IQR,3–10] in non-frail group, p = 0.051. The median hospital LOS in frail patients was 18 days [IQR,10–32] compared to 15 days [IQR, 8.25-26] in non-frail, p = 0.005. ICU, hospital and 30-day mortality were significantly higher in frail patients, p < 0.01. The prevalence of frailty in ICU patients was 24.6% and a higher number of frail patients had requirement of vasopressor support and incidence of HAI. Additionally, frail patients also had longer hospital LOS and higher ICU, hospital and 30-day mortality. CTRI/2021/04/032782.
- 26 April 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-11
Open AccessPrevalence of frailty and its effect on requirement of organ support and clinical outcomes in critically ill patients: a prospective observational single center study
Assessing pre-hospital frailty on ICU admission can help in risk stratification. We conducted this prospective, observational study to determine the prevalence of frailty in critically ill patients based on Clinical Frailty Scale (CFS) within 24 h of admission and to study effect of frailty on requirement of organ support and clinical outcome. The study was registered in Clinical Trials Registry-India (CTRI/2021/04/032782) on 13/04/2021. After approval from IEC and written informed consent, all adult patients admitted to our ICU from April 15th, 2021 to April 14th, 2022 were included. The patients were categorized as Frail & Non-Frail, defining frailty as CFS ≥ 5, two weeks before index admission. The groups were compared for requirement of organ support (vasoactive support, mechanical ventilation, renal replacement therapy) and clinical outcomes (hospital acquired infections (HAI), hospital and ICU length of stay (LOS) and hospital, ICU and 30-day mortality). Out of 358 admissions, 317 were enrolled. The demographic data were comparable except for higher family income amongst frail patients, p < 0.001. The prevalence of frailty was 24.6%. A significantly higher number of frail patients required vasoactive support (p = 0.006). Incidence of HAI in frail group was significantly higher (48.7%) as compared to non-frail group (20.9%) (p < 0.001). The median ICU LOS was 7 days [IQR, 3–7] in frail compared to 6 days [IQR,3–10] in non-frail group, p = 0.051. The median hospital LOS in frail patients was 18 days [IQR,10–32] compared to 15 days [IQR, 8.25-26] in non-frail, p = 0.005. ICU, hospital and 30-day mortality were significantly higher in frail patients, p < 0.01. The prevalence of frailty in ICU patients was 24.6% and a higher number of frail patients had requirement of vasopressor support and incidence of HAI. Additionally, frail patients also had longer hospital LOS and higher ICU, hospital and 30-day mortality. CTRI/2021/04/032782.
- Open Access
- 13 March 2025
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 69 (4) , 335-342
Continuous peripheral nerve block in patients with proximal femur fracture: A randomised comparison of three techniques
Background and Aims: The literature mentions numerous approaches to peripheral nerve blockade for pain management following proximal femur fractures. We aimed to explore the best analgesic option in these patients while comparing blocks of the femoral nerve and fascia iliaca compartment. Methods: Sixty consenting adult trauma patients admitted with proximal femur fractures for surgical fixation under general anaesthesia were randomised to receive either sonography-guided continuous fascia iliaca plane block employing suprainguinal (SFICB group) or infrainguinal (IFICB group) approach or femoral nerve block (FNB group) for postoperative analgesia, using 0.2% ropivacaine as initial bolus (volume based on patient’s weight), followed by its continuous infusion @10 mL/h for first 24 h. Intravenous morphine was used as a rescue analgesic (RA) to keep a visual analogue scale (VAS) score of P = 0.044), significantly decreased VAS scores, and reported superior quality of pain relief. Conclusion: Following proximal femur fracture surgery, superior pain relief was provided by continuous suprainguinal fascia iliaca compartment block compared to the infrainguinal approach or simple femoral nerve block.
- 13 March 2025
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 69 (4) , 335-342
Open AccessContinuous peripheral nerve block in patients with proximal femur fracture: A randomised comparison of three techniques
Background and Aims: The literature mentions numerous approaches to peripheral nerve blockade for pain management following proximal femur fractures. We aimed to explore the best analgesic option in these patients while comparing blocks of the femoral nerve and fascia iliaca compartment. Methods: Sixty consenting adult trauma patients admitted with proximal femur fractures for surgical fixation under general anaesthesia were randomised to receive either sonography-guided continuous fascia iliaca plane block employing suprainguinal (SFICB group) or infrainguinal (IFICB group) approach or femoral nerve block (FNB group) for postoperative analgesia, using 0.2% ropivacaine as initial bolus (volume based on patient’s weight), followed by its continuous infusion @10 mL/h for first 24 h. Intravenous morphine was used as a rescue analgesic (RA) to keep a visual analogue scale (VAS) score of P = 0.044), significantly decreased VAS scores, and reported superior quality of pain relief. Conclusion: Following proximal femur fracture surgery, superior pain relief was provided by continuous suprainguinal fascia iliaca compartment block compared to the infrainguinal approach or simple femoral nerve block.
- Open Access
- 12 April 2024
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 68 (5) , 480-485
Effective concentration (EC50) of sevoflurane for intraocular pressure measurement in anaesthetised children with glaucoma: A dose-finding study
Background and Aim: Sevoflurane, a preferred anaesthetic for children, exhibits a dose-dependent reduction in intraocular pressure (IOP). However, consensus is lacking regarding optimal end-tidal sevoflurane concentration for safe IOP measurement. This study aimed to identify the concentration at which IOP measurement could be attempted without inducing movements in paediatric patients after inhalational induction. Methods: Two paediatric groups (1–12 months and 12–36 months) with glaucoma undergoing examination under anaesthesia were recruited. After induction with 8% sevoflurane and 100% oxygen, the first child had an end-tidal sevoflurane concentration maintained at 2% for 4 min, followed by IOP measurement. Success was defined as ‘no movement’, and subsequent concentrations (adjusted in 0.2% steps) were determined using the Dixon and Massey method based on the previous patient’s responses. Results: The study included 75 children. The effective concentration of sevoflurane causing ‘no movement’ during IOP measurement in 50% of the study population for successful IOP measurement was 1.98% (95% confidence interval [CI] 1.63, 2.17, P = 0.017) for 1–12 months group and 0.55% (95% CI 0.39, 0.66, P = 0.002) for 12–36 months group. Probit regression analysis yielded effective concentration of sevoflurane causing ‘no movement’ during IOP measurement in 95% of the study population values of 2.47% (95% CI 2.24, 4.58, P = 0.017) for 1–12 months group and 0.94% (95% CI 0.78, 1.57, P = 0.002) for 12–36 months group. Conclusion: In paediatric patients, a higher end-tidal sevoflurane concentration of 2% is needed for IOP measurement in 1–12 months age group compared to 0.5% required in 12–36 months age group, achieving success in 50% of the study population.
- 12 April 2024
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 68 (5) , 480-485
Open AccessEffective concentration (EC50) of sevoflurane for intraocular pressure measurement in anaesthetised children with glaucoma: A dose-finding study
Background and Aim: Sevoflurane, a preferred anaesthetic for children, exhibits a dose-dependent reduction in intraocular pressure (IOP). However, consensus is lacking regarding optimal end-tidal sevoflurane concentration for safe IOP measurement. This study aimed to identify the concentration at which IOP measurement could be attempted without inducing movements in paediatric patients after inhalational induction. Methods: Two paediatric groups (1–12 months and 12–36 months) with glaucoma undergoing examination under anaesthesia were recruited. After induction with 8% sevoflurane and 100% oxygen, the first child had an end-tidal sevoflurane concentration maintained at 2% for 4 min, followed by IOP measurement. Success was defined as ‘no movement’, and subsequent concentrations (adjusted in 0.2% steps) were determined using the Dixon and Massey method based on the previous patient’s responses. Results: The study included 75 children. The effective concentration of sevoflurane causing ‘no movement’ during IOP measurement in 50% of the study population for successful IOP measurement was 1.98% (95% confidence interval [CI] 1.63, 2.17, P = 0.017) for 1–12 months group and 0.55% (95% CI 0.39, 0.66, P = 0.002) for 12–36 months group. Probit regression analysis yielded effective concentration of sevoflurane causing ‘no movement’ during IOP measurement in 95% of the study population values of 2.47% (95% CI 2.24, 4.58, P = 0.017) for 1–12 months group and 0.94% (95% CI 0.78, 1.57, P = 0.002) for 12–36 months group. Conclusion: In paediatric patients, a higher end-tidal sevoflurane concentration of 2% is needed for IOP measurement in 1–12 months age group compared to 0.5% required in 12–36 months age group, achieving success in 50% of the study population.
- Open Access
- 1 January 2024
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 36
Eficácia da melatonina na redução da incidência de delirium em pacientes adultos graves: um ensaio clínico randomizado
RESUMO Objetivo: Determinar se a melatonina enteral diminui a incidência de delirium em adultos em estado grave. Métodos: Neste estudo controlado e randomizado, os adultos foram admitidos à unidade de terapia intensiva e/ou receberam apenas o padrão de cuidado habitual (Grupo Controle) ou o tratamento combinado com 3mg de melatonina enteral uma vez ao dia às 21h (Grupo Melatonina). A ocultação da alocação foi feita por meio de envelopes selados opacos e numerados sequencialmente. O intensivista que avaliou o delirium e o pesquisador que realizou a análise dos dados foram cegados quanto à alocação do grupo. O desfecho primário foi a incidência de delirium dentro de 24 horas de internação na unidade de terapia intensiva. Os desfechos secundários foram a incidência de delirium nos dias 3 e 7, a mortalidade na unidade de terapia intensiva, a duração da internação na unidade de terapia intensiva, a duração da ventilação mecânica e o escore da escala de desfecho de Glasgow (na alta). Resultados: Foram incluídos 108 pacientes na análise final, com 54 sujeitos em cada grupo. Em 24 horas de internação na unidade de terapia intensiva, a incidência de delirium não foi diferente entre os Grupos Melatonina e Controle (29,6% versus 46,2%; RR = 0,6; IC95% 0,38 - 1,05; p = 0,11). Nenhum desfecho secundário apresentou diferenças estatisticamente significativas. Conclusão: Em adultos em estado grave, 3mg de melatonina enteral não foi mais eficaz que os cuidados padrão na redução da incidência de delirium.
- 1 January 2024
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 36
Open AccessEficácia da melatonina na redução da incidência de delirium em pacientes adultos graves: um ensaio clínico randomizado
RESUMO Objetivo: Determinar se a melatonina enteral diminui a incidência de delirium em adultos em estado grave. Métodos: Neste estudo controlado e randomizado, os adultos foram admitidos à unidade de terapia intensiva e/ou receberam apenas o padrão de cuidado habitual (Grupo Controle) ou o tratamento combinado com 3mg de melatonina enteral uma vez ao dia às 21h (Grupo Melatonina). A ocultação da alocação foi feita por meio de envelopes selados opacos e numerados sequencialmente. O intensivista que avaliou o delirium e o pesquisador que realizou a análise dos dados foram cegados quanto à alocação do grupo. O desfecho primário foi a incidência de delirium dentro de 24 horas de internação na unidade de terapia intensiva. Os desfechos secundários foram a incidência de delirium nos dias 3 e 7, a mortalidade na unidade de terapia intensiva, a duração da internação na unidade de terapia intensiva, a duração da ventilação mecânica e o escore da escala de desfecho de Glasgow (na alta). Resultados: Foram incluídos 108 pacientes na análise final, com 54 sujeitos em cada grupo. Em 24 horas de internação na unidade de terapia intensiva, a incidência de delirium não foi diferente entre os Grupos Melatonina e Controle (29,6% versus 46,2%; RR = 0,6; IC95% 0,38 - 1,05; p = 0,11). Nenhum desfecho secundário apresentou diferenças estatisticamente significativas. Conclusão: Em adultos em estado grave, 3mg de melatonina enteral não foi mais eficaz que os cuidados padrão na redução da incidência de delirium.
- Open Access
- 1 January 2024
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 36
Efficacy of melatonin in decreasing the incidence of delirium in critically ill adults: a randomized controlled trial
Objective: To determine whether enteral melatonin decreases the incidence of delirium in critically ill adults. Methods: In this randomized controlled trial, adults were admitted to the intensive care unit and received either usual standard care alone (Control Group) or in combination with 3mg of enteral melatonin once a day at 9 PM (Melatonin Group). Concealment of allocation was done by serially numbered opaque sealed envelopes. The intensivist assessing delirium and the investigator performing the data analysis were blinded to the group allocation. The primary outcome was the incidence of delirium within 24 hours of the intensive care unit stay. The secondary outcomes were the incidence of delirium on Days 3 and 7, intensive care unit mortality, length of intensive care unit stay, duration of mechanical ventilation and Glasgow outcome score (at discharge). Results: We included 108 patients in the final analysis, with 54 patients in each group. At 24 hours of intensive care unit stay, there was no difference in the incidence of delirium between Melatonin and Control Groups (29.6 versus 46.2%; RR = 0.6; 95%CI 0.38 - 1.05; p = 0.11). No secondary outcome showed a statistically significant difference. Conclusion: Enteral melatonin 3mg is not more effective at decreasing the incidence of delirium than standard care is in critically ill adults.
- 1 January 2024
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 36
Open AccessEfficacy of melatonin in decreasing the incidence of delirium in critically ill adults: a randomized controlled trial
Objective: To determine whether enteral melatonin decreases the incidence of delirium in critically ill adults. Methods: In this randomized controlled trial, adults were admitted to the intensive care unit and received either usual standard care alone (Control Group) or in combination with 3mg of enteral melatonin once a day at 9 PM (Melatonin Group). Concealment of allocation was done by serially numbered opaque sealed envelopes. The intensivist assessing delirium and the investigator performing the data analysis were blinded to the group allocation. The primary outcome was the incidence of delirium within 24 hours of the intensive care unit stay. The secondary outcomes were the incidence of delirium on Days 3 and 7, intensive care unit mortality, length of intensive care unit stay, duration of mechanical ventilation and Glasgow outcome score (at discharge). Results: We included 108 patients in the final analysis, with 54 patients in each group. At 24 hours of intensive care unit stay, there was no difference in the incidence of delirium between Melatonin and Control Groups (29.6 versus 46.2%; RR = 0.6; 95%CI 0.38 - 1.05; p = 0.11). No secondary outcome showed a statistically significant difference. Conclusion: Enteral melatonin 3mg is not more effective at decreasing the incidence of delirium than standard care is in critically ill adults.
- 29 June 2022
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 91 (2) , 119-124
Effect of CoolSense and EMLA Cream on Pain During Intravenous Cannulation in Pediatric Population: A Randomized, Controlled Trial
Objective To compare the efficacy of CoolSense and EMLA cream on pain reduction during intravenous cannulation in the pediatric population. Methods A total of 140 American Society of Anesthesiologist I/II children of 6–12 y requiring intravenous cannulation before induction of anesthesia were randomized into two groups of 70 each. Before intravenous cannulation, group I received CoolSense pretreatment while group II received EMLA cream pretreatment. The primary outcome was to assess the efficacy of CoolSense and EMLA cream on pain reduction during intravenous cannulation. The secondary outcomes included the anxiety level of children, successful first attempt at cannulation, technical difficulties faced, adverse reactions, and parents’ satisfaction score. Results There was a significant reduction in pain scores during intravenous cannulation in the CoolSense group compared to the EMLA cream group (mean pain score 7.14 ± 4.322 versus 29.32 ± 8.95, p value 0.001). Comparison of pre- and postprocedural anxiety levels showed a decrease in the anxiety level in the CoolSense group (p value = 0.003) as compared to the EMLA group. The duration of application of CoolSense was significantly less than EMLA cream. Conclusion CoolSense was more efficacious in reducing the pain of intravenous cannulation than the EMLA cream. In the pediatric population, CoolSense appears to be a simple and rapid means of providing adequate analgesia for venous cannulation.
- 29 June 2022
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 91 (2) , 119-124
Effect of CoolSense and EMLA Cream on Pain During Intravenous Cannulation in Pediatric Population: A Randomized, Controlled Trial
Objective To compare the efficacy of CoolSense and EMLA cream on pain reduction during intravenous cannulation in the pediatric population. Methods A total of 140 American Society of Anesthesiologist I/II children of 6–12 y requiring intravenous cannulation before induction of anesthesia were randomized into two groups of 70 each. Before intravenous cannulation, group I received CoolSense pretreatment while group II received EMLA cream pretreatment. The primary outcome was to assess the efficacy of CoolSense and EMLA cream on pain reduction during intravenous cannulation. The secondary outcomes included the anxiety level of children, successful first attempt at cannulation, technical difficulties faced, adverse reactions, and parents’ satisfaction score. Results There was a significant reduction in pain scores during intravenous cannulation in the CoolSense group compared to the EMLA cream group (mean pain score 7.14 ± 4.322 versus 29.32 ± 8.95, p value 0.001). Comparison of pre- and postprocedural anxiety levels showed a decrease in the anxiety level in the CoolSense group (p value = 0.003) as compared to the EMLA group. The duration of application of CoolSense was significantly less than EMLA cream. Conclusion CoolSense was more efficacious in reducing the pain of intravenous cannulation than the EMLA cream. In the pediatric population, CoolSense appears to be a simple and rapid means of providing adequate analgesia for venous cannulation.
- Open Access
- 1 December 2019
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 72 (6) , 570-575
Comparison of Air-QⓇ insertion techniques in pediatric patients with fiber-optic bronchoscopic assessment: a prospective randomized control trial
Background: Air-Q (R) laryngeal mask airway (LMA) is a second-generation supraglottic airway device (SAD) providing adequate airway control despite the unfavorable airway anatomy in children. Several studies have assessed it as a conduit for tracheal intubation and compared its efficacy with that of other SADs, but there are no studies comparing the laryngeal view with midline and rotational insertion techniques of Air-Q. Therefore, this study compared the fiber-optic bronchoscopic (FOB) assessment of the Air-Q position using these two insertion techniques. Methods: This randomized controlled trial included 80 patients of the American Society of Anesthesiologists physical status I/II of either sex (age group 5-12 years, weight 10-30 kg), who were scheduled for elective surgery in the supine position under general anesthesia. The patients were randomly subjected to rotational and midline technique groups (n = 40, each), and appropriate sized Air-Q, based on the weight of the patient, was inserted using the technique allocated to each patient. Time taken and number of attempts for successful insertion of the devices and any complications after removal of device were studied. Results: FOB grade 1 (ideal position) was seen in 29/40 (72.5%) and 19/40 (47.5%) children subjected to the rotational and classic midline techniques, respectively (P = 0.045). The time taken to successfully insert the Air-Q was significantly lesser in the rotational technique group (7.2 +/- 1.5 s) than in the classic midline technique group (10.2 +/- 2.1 s) (P < 0.001), whereas complications were similar in both groups. Conclusions: The rotational technique was associated with better FOB view, and was faster than the classic midline technique of Air-Q insertion in pediatric patients.
- 1 December 2019
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 72 (6) , 570-575
Open AccessComparison of Air-QⓇ insertion techniques in pediatric patients with fiber-optic bronchoscopic assessment: a prospective randomized control trial
Background: Air-Q (R) laryngeal mask airway (LMA) is a second-generation supraglottic airway device (SAD) providing adequate airway control despite the unfavorable airway anatomy in children. Several studies have assessed it as a conduit for tracheal intubation and compared its efficacy with that of other SADs, but there are no studies comparing the laryngeal view with midline and rotational insertion techniques of Air-Q. Therefore, this study compared the fiber-optic bronchoscopic (FOB) assessment of the Air-Q position using these two insertion techniques. Methods: This randomized controlled trial included 80 patients of the American Society of Anesthesiologists physical status I/II of either sex (age group 5-12 years, weight 10-30 kg), who were scheduled for elective surgery in the supine position under general anesthesia. The patients were randomly subjected to rotational and midline technique groups (n = 40, each), and appropriate sized Air-Q, based on the weight of the patient, was inserted using the technique allocated to each patient. Time taken and number of attempts for successful insertion of the devices and any complications after removal of device were studied. Results: FOB grade 1 (ideal position) was seen in 29/40 (72.5%) and 19/40 (47.5%) children subjected to the rotational and classic midline techniques, respectively (P = 0.045). The time taken to successfully insert the Air-Q was significantly lesser in the rotational technique group (7.2 +/- 1.5 s) than in the classic midline technique group (10.2 +/- 2.1 s) (P < 0.001), whereas complications were similar in both groups. Conclusions: The rotational technique was associated with better FOB view, and was faster than the classic midline technique of Air-Q insertion in pediatric patients.